In this brave new world of Twitter, Facebook, LinkedIn and other social media websites, risk and opportunity may be combined. There is no question that social networking represents the emergence of a tremendous marketing and customer education opportunity, but there are also pitfalls for the FDA-regulated company. What happens if you go too far, say too much? Do you need to be concerned about the use of these networking sites by employees?

This audio conference presentation tackles some of the important issues that social media poses for life science companies – the benefits, risks, and mitigating that risk – and provides insight on how to use social media to positively impact your business, without running afoul of regulators.

This audio conference covers:

• Drawing the line between legitimate brand projections via social media and over-promotion
• Harnessing social media to educate patients and medical professionals regarding drugs and devices in a compliant manner
• The FDA regulatory and product liability implications for companies using social media
• Mitigating product liability risks associated with use of social media
• How involved should companies be in monitoring employees' use of social media both at work and at home?

About the speaker:

Kelly Savage Day, Senior Associate at Sedgwick LLP has served as national, regional and state counsel for a variety of clients, who utilize her ability to handle complex product liability litigation in state and federal court, at both the trial and appellate levels.

In addition to her trial work, Kelly counsels clients on FDA regulatory compliance, including post-approval issues such as labeling changes, adverse event reporting, good manufacturing requirements and promotional activities. She also provides crisis management counseling on product recalls, government investigations and similar issues.

Kelly has authored more than 20 articles on legal topics relating to the defense of pharmaceutical and medical device companies in product liability litigation. As a leading authority in the field, she is often interviewed by and quoted in the national media. She has appeared in Forbes, The Wall Street Journal and numerous trade publications as an expert on generic drugs, product liability issues, and preemption.

Who should attend?

• Legal Counsel
• Compliance
• Sales & Business Development
• Marketing
• Advertising
• Public Relations